Skip to contentL
Ligand Pharmaceuticals Inc
L
LGNDLigand Pharmaceuticals Inc Source filing unavailable
Q2 2012 · —
Revenue$5.64M$5.64Mno prior Q2 2011 on file Net Income$1.13M$1.13Mno prior Q2 2011 on file EPS Diluted$0.06$0.06no prior Q2 2011 on file Operating Income$3,932,000— Operating Cash Flow$2,078,000— Free Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ligand Pharmaceuticals Inc · CIK 886163 · Engraved from SEC EDGAR
Margins · derivedOperating margin69.8%
Net margin20.1%